• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS M.R.I. LOW-PROFILE IMPLANTABLE PORT WITH ATTACHABLE 7F GROSHONG; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS M.R.I. LOW-PROFILE IMPLANTABLE PORT WITH ATTACHABLE 7F GROSHONG; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 0603870
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code Injury (2348)
Date of Event 11/14/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.
 
Event or Problem Description
It was reported that approximately ten months post port system placement in the right internal jugular for chemotherapy treatment of colon cancer, the catheter allegedly migrated into the lung identified via ct scan.It was further reported that the catheter was removed.The patient status is unknown post removal procedural.
 
Event or Problem Description
It was reported that approximately ten months post port system placement in the right internal jugular for chemotherapy treatment of colon cancer, the catheter allegedly migrated into the lung identified via ct scan.It was further reported that the catheter was removed.The patient status is unknown post removal procedural.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one mri lp port and cath lock were returned for evaluation.Functional, gross visual and microscopic visual evaluations were performed.The investigation is inconclusive for catheter break, as no fragments from the catheter were returned.The port appeared to have been used, as there were multiple punctures to the port septum.The port body was patent to infusion and aspiration.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documents (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Images and medical records were not provided for review.Therefore, the investigation is inconclusive for the alleged catheter embolization as no objective evidence has been provided to confirm any alleged deficiency with the catheter.The root cause could not be determined based upon available information.It is unknown whether patient and/or procedural factors contributed to the event.Possible contributing factors include over-pressurization, flexural fatigue, and pinch-off; however, the lack of a returned sample prevented both confirmation of the reported event and identification of a root cause(s).Labeling review: a review of product labeling documents (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.
 
Event or Problem Description
It was reported that approximately ten months post port system placement in the right internal jugular for chemotherapy treatment of colon cancer, the catheter allegedly migrated into the lung identified via ct scan.It was further reported that the catheter was removed.The patient status is unknown post removal procedural.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.R.I. LOW-PROFILE IMPLANTABLE PORT WITH ATTACHABLE 7F GROSHONG
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key8464973
Report Number3006260740-2019-00722
Device Sequence Number11510576
Product Code LJT
UDI-Device Identifier00801741025839
UDI-Public(01)00801741025839
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K924250
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number0603870
Device Catalogue Number0603870
Device Lot NumberREAW1019
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/24/2019
Initial Date Received by Manufacturer 03/04/2019
Supplement Date Received by Manufacturer04/02/2019
07/25/2019
Initial Report FDA Received Date03/29/2019
Supplement Report FDA Received Date04/03/2019
07/29/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-